Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease
Saudi Pharmaceutical Journal · 2026-04 · 34 (2)
DOI: 10.1007/s44446-026-00063-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, online erschienen am 17.03.2026. Verfasst von Hadeel Drweesh und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, King Saud University, P. O. Box 2457, 11451, Riyadh, Saudi Arabia. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, King Saud University, P. O. Box 2457, 11451, Riyadh, Saudi Arabia.
- King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
- King Fahd Specialist Hospital, Dammam, Saudi Arabia.
- Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar.
- Pharmaceutical Care Department, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Zitieren
APA
Drweesh, H., Alotaibi, A., Alqassim, H. A., Eid, M. M., Emsaad, S. A., Saad, M. O., Higazy, A. S., Alturaiki, A., Almutairi, F., Alhussain, A., Assiri, A., Alkofide, H., Alruthia, Y., Albassam, A., & Alsultan, A. (2026). Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease. Saudi Pharmaceutical Journal, 34(2). https://doi.org/10.1007/s44446-026-00063-5
Vancouver
Drweesh H, Alotaibi A, Alqassim HA, Eid MM, Emsaad SA, Saad MO, et al. Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease. Saudi Pharmaceutical Journal. 2026;34(2). doi:10.1007/s44446-026-00063-5
BibTeX
@article{Drweesh2026,
author = {Drweesh, Hadeel and Alotaibi, Amal and Alqassim, Hussain Abdalghani and Eid, Mohammed Mustafa and Emsaad, Shaimaa Abdulhadi and Saad, Mohamed Omar and Higazy, Alya Salah and Alturaiki, Abdulrahman and Almutairi, Fares and Alhussain, Abdulsattar and Assiri, Abdulmohsen and Alkofide, Hadeel and Alruthia, Yazeed and Albassam, Ahmed and Alsultan, Abdullah},
title = {Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease},
journal = {Saudi Pharmaceutical Journal},
year = {2026},
volume = {34},
number = {2},
doi = {10.1007/s44446-026-00063-5}
}
EUVIMED